STUDY OF INCIDENCE OF BLEEDING IN PATIENTS OF AMI AFTER THROMBOLYTIC THERAPY · Abstract : · Keywords : · Article: Download PDF DOI : 10.36106/ijar. Cite This ...
Aug 25, 2023 · Elderly patients with low body weight and females are at increased risk of bleeding following thrombolytic treatment [12]. However, the rate and ...
When the patients receiving SK as the thrombolytic agent were evaluated within GUSTO II, a striking reduction in mortality and other adverse events was evident.
Missing: "IJAR -" | Show results with:"IJAR -"
Lanoteplase and heparin bolus plus infusion is as effective as tPA with regard to mortality, but the rate of intracranial hemorrhage is significantly higher.
Missing: "IJAR -" | Show results with:"IJAR -"
Oct 13, 2020 · Serious bleeding complications, especially intracranial bleeding, limited recanalization rates, and rapid clearance requiring a 1- to 3-hour ...
Activase® (alteplase) is indicated for the treatment of acute ischemic stroke. Exclude intracranial hemorrhage as the primary cause of stroke signs and symptoms ...
Dec 1, 2001 · We did a randomised, open-label trial to compare the thrombin-specific anticoagulant, bivalirudin, with heparin in patients undergoing ...
Feb 23, 2022 · An incidence of AF of 10.4% was registered in the GUSTO I study among patients with AMI treated with fibrinolytic therapy [18]. Among the first ...
Jan 3, 2023 · This cohort study evaluates the risk of symptomatic intracranial hemorrhage associated with use of intravenous thrombolysis in patients with ...
Missing: "IJAR -" | Show results with:"IJAR -"
People also ask
Is bleeding the most common side effect of treatment with thrombolytics?
What is the antidote for bleeding due to thrombolytics?
What is the risk of intracranial hemorrhage with tPA for PE?
factors for bleeding AMI in a patients receiving thrombolytic therapy at coronary care. ... International Journal of Scientific Research. 2019; 8 (4): 51-52. 12.
